TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
JSPR

Jasper Therapeutics Inc

Healthcare · Biotechnology

0.6091$ +4.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet JSPR
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
99.8% 88.6% 93.8% 86.3% 93.7% 94.9% 96.8%
99.8% 84.9% 90.4% 79.1% 91.6% 89.7% 80.2%
99.8% 84.9% 90.4% 79.1% 91.6% 89.7% 80.2%
– 2.6% 0.7% 2.4% 0.3% – –
– 0.4% -0.6% – – – –
– 8.7% 5.2% 7.4% – – –
22.5% 250.4% 25.8% 25.6% 17.3% 22.8% 88.4%
7.3% 17.2% 8.6% 14.6% 13.0% 19.1% 36.9%
– – 0.5% 1.8% 1.0% 1.4% 3.5%
2.3% 6.1% 4.2% 3.7% 4.4% 5.0% 17.4%
– 56.2% – – – – –
77.5% -150.4% 74.2% 74.4% 82.7% 77.2% 11.6%
-18.9% -157.6% -72.0% -217.4% -178.7% -301.5% -885.1%
0.6% 0.7% 1.2% 7.5% 11.0% 18.3% 53.6%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?